These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6121387

  • 21. [Double blind study of migraine therapy with etilefrine pivalate].
    Cruz A, Bühling M, Seibel K.
    Arzneimittelforschung; 1985; 35(7):1086-9. PubMed ID: 2864937
    [Abstract] [Full Text] [Related]

  • 22. [Dihydroergotamine and orthostatic hypotension in elective hip surgery].
    Hjortdal VE, Nielsen BW, Møller-Larsen F, Lassen MR, Borris LC, Christiansen HM.
    Ugeskr Laeger; 1989 Jul 03; 151(27):1749-51. PubMed ID: 2551088
    [Abstract] [Full Text] [Related]

  • 23. [Comparative studies of the efficacy of amezinium and etilefrin in aged patients with hypotonic blood circulation regulatory disorders].
    Jansen W.
    Med Welt; 1982 Oct 02; 32(40):1491-6. PubMed ID: 6125868
    [No Abstract] [Full Text] [Related]

  • 24. Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory disorders: a double-blind comparison with placebo.
    Krüger K, Neff K.
    J Med; 1973 Oct 02; 4(2):106-17. PubMed ID: 4584070
    [No Abstract] [Full Text] [Related]

  • 25. A controlled study with Dihydergot on patients with orthostatic dysregulation.
    Lübke KO.
    Cardiology; 1976 Oct 02; 61 suppl 1():333-41. PubMed ID: 788910
    [Abstract] [Full Text] [Related]

  • 26. [Therapy of hypotonic cardiovascular regulation disorders with amezinium (Regulton) and dihydroergotamine].
    Bückert C.
    Fortschr Med; 1981 Aug 13; 99(30):1202-6. PubMed ID: 7024066
    [No Abstract] [Full Text] [Related]

  • 27. [Orthostatic hypotension. An attempt to simplify diagnosis -- treatment with dihydergot in general practice(author's transl)].
    Probst G.
    Schweiz Rundsch Med Prax; 1975 Jun 10; 64(23):730-4. PubMed ID: 1099574
    [No Abstract] [Full Text] [Related]

  • 28. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P, Mallaret M, Gaio JM, Hommel M, Perret J.
    Adv Neurol; 1987 Jun 10; 45():263-6. PubMed ID: 3548261
    [No Abstract] [Full Text] [Related]

  • 29. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF, Aebi B.
    Chirurg; 1983 Jan 10; 54(1):29-32. PubMed ID: 6851723
    [Abstract] [Full Text] [Related]

  • 30. Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.
    Barthel W, Glusa E, Koth W.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb 10; 25(2):63-9. PubMed ID: 2881898
    [Abstract] [Full Text] [Related]

  • 31. [Therapy of orthostatic circulatory lability. Oral dihydroergotamine in various galenic preparations in comparative studies on orthostasis reactions].
    Kayser-Petersen E.
    Fortschr Med; 1978 Jul 06; 96(25):1339-42. PubMed ID: 669523
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of intramuscular dihydroergotamine on blood circulation in the early postoperative phase. A clinical study].
    Martin E, Immich H, Lutz H, Peter K.
    Med Klin; 1976 May 28; 71(22):961-5. PubMed ID: 778569
    [Abstract] [Full Text] [Related]

  • 33. [The use of Thomasin (etilefrin) in patients with basic neuroleptic, antidepressive and antiepileptic medication].
    Börner I, Gretzler H, Herbst A, Schläfke D.
    Z Arztl Fortbild (Jena); 1982 Sep 01; 76(17):781-3. PubMed ID: 6128833
    [No Abstract] [Full Text] [Related]

  • 34. Dihydroergotamine increases the bioavailability of orally administered etilefrine.
    Hengstmann JH, Hengstmann R, Schwonzen S, Dengler HJ.
    Eur J Clin Pharmacol; 1982 Sep 01; 22(5):463-7. PubMed ID: 6126364
    [Abstract] [Full Text] [Related]

  • 35. [Orthostatic regulation and its modification by amezinium].
    Rieckert H.
    Med Welt; 1983 Jan 14; 34(2):60-2. PubMed ID: 6827961
    [No Abstract] [Full Text] [Related]

  • 36. [Problem of orthostatic intolerance in astronauts and perspectives for its pharmacological prevention].
    Shashkov VS, Modin AIu.
    Aviakosm Ekolog Med; 1998 Jan 14; 32(4):13-7. PubMed ID: 9858980
    [Abstract] [Full Text] [Related]

  • 37. [Is a single dose of dihydroergotamine per day sufficient?].
    Jansen W, Enghofer E, Seibel K.
    MMW Munch Med Wochenschr; 1983 Jun 10; 125(23):498-502. PubMed ID: 6410213
    [No Abstract] [Full Text] [Related]

  • 38. [Double blind study on the hemodynamic effects of amezinium methlsulfate in patients with orthostatic circulatory disorders (author's transl)].
    Belz GG, Aust PE, Belz G.
    Z Kardiol; 1981 Sep 10; 70(9):706-12. PubMed ID: 7303809
    [No Abstract] [Full Text] [Related]

  • 39. [Interaction of dihydroergotamine and etilefrine-hydrochloride at capacitance vessels of the calf in man (author's transl)].
    Inoue H, Inoue K, Arndt JO.
    Z Kardiol; 1980 Apr 10; 69(4):280-6. PubMed ID: 6109407
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.